WORLD'S FIRST PATENT ACQUIRED FOR ANIMAL SUPPLEMENT "PINFENON" (S) (R)

TOKYO, Nov 12 (Bernama) --

- Patent Covers Invention of Treatment Drug and Prophylactic Drug for Lowering Cardiac Disorder Markers in Dogs as Well as Their Manufacturing Methods -

Scarecrow Incorporated, based in Tokyo's Shibuya Ward, is pleased to announce that it has acquired the world's first (*) patent for Pinfenon (S) (R), an animal supplement made in Japan, associated with a treatment drug and a prophylactic drug for lowering the atrial natriuretic peptide (ANP) as well as their manufacturing methods. The supplements approved as drugs by the Japan Patent Office are subject to technical transfer in such products as food, shampoos, and essences as new means of allowing anyone to protect small dogs from cardiac disorders.